J. Markman
Molecular Biology · 2013
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it
- Biomaterials — 8 citations into it
Whom J. Markman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Markman's perspective
Ordered by how strongly the researchers J. Markman trusts endorse each paper. Same corpus, a different order for every researcher.
- Prospective identification of tumorigenic breast cancer cells (Proceedings of the National Academy of Sciences of the United States of America)
- Hallmarks of cancer: the next generation. (Cell)
- Stem cells, cancer, and cancer stem cells (Nature)
- Identification of human brain tumour initiating cells (Nature)
- Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity (Nature Immunology)
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing (New England Journal of Medicine)
- EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. (Proceedings of the National Academy of Sciences of the United States of America)
- A human colon cancer cell capable of initiating tumour growth in immunodeficient mice (Nature)
- Identification and expansion of human colon-cancer-initiating cells (Nature)
- Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. (Cancer Research)
Their papers
- Nanomedicine therapeutic approaches to overcome cancer drug resistance (2013) — 675 citations